Early Neurological Deterioration following Intravenous Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Lacunar Stroke

Publisher： Karger

E-ISSN： 1421-9786|26|4|355-359

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.26, Iss.4, 2008-08, pp. : 355-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study

By  

Cerebrovascular Diseases, Vol. 42, Iss. 1-2, 2016-03 ,pp. : 41-48

Karger

Access to resources Recommend Favorite

Repeated Intravenous Treatment with Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-09 ,pp. : 127-134

Karger

Access to resources Recommend Favorite

Intravenous Recombinant Tissue Plasminogen Activator Therapy for Stroke Patients Receiving Maintenance Hemodialysis: The Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA Registry

By  

European Neurology, Vol. 66, Iss. 1, 2011-06 ,pp. : 37-41

Karger

Access to resources Recommend Favorite

Negative Fluid-Attenuated Inversion Recovery- Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time

By  

Cerebrovascular Diseases Extra, Vol. 3, Iss. 1, 2013-03 ,pp. : 35-45

Karger

Access to resources Recommend Favorite

Intravenous Thrombolysis for Acute Ischaemic Stroke: Preliminary Experience with Recombinant Tissue Plasminogen Activator in the UK

By  

Cerebrovascular Diseases, Vol. 20, Iss. 6, 2005-11 ,pp. : 438-442

Karger

Access to resources Recommend Favorite